333 related articles for article (PubMed ID: 12538474)
1. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression.
Maurer TA; Christian KV; Kerschmann RL; Berzin B; Palefsky JM; Payne D; Tyring SK; Berger TG
Arch Dermatol; 1997 May; 133(5):577-83. PubMed ID: 9158410
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
[TBL] [Abstract][Full Text] [Related]
4. p53 gene mutations in human epithelial skin cancers.
Molès JP; Moyret C; Guillot B; Jeanteur P; Guilhou JJ; Theillet C; Basset-Sèguin N
Oncogene; 1993 Mar; 8(3):583-8. PubMed ID: 8437842
[TBL] [Abstract][Full Text] [Related]
5. Carcinogen-specific mutation pattern in the p53 tumour suppressor gene in UV radiation-induced basal cell carcinoma.
Weihrauch M; Bader M; Lehnert G; Wittekind C; Tannapfel A; Wrbitzky R
Int Arch Occup Environ Health; 2002 Apr; 75(4):272-6. PubMed ID: 11981662
[TBL] [Abstract][Full Text] [Related]
6. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene.
Queille S; Luron L; Spatz A; Avril MF; Ribrag V; Duvillard P; Hiesse C; Sarasin A; Armand JP; Daya-Grosjean L
Carcinogenesis; 2007 Mar; 28(3):724-31. PubMed ID: 17065198
[TBL] [Abstract][Full Text] [Related]
7. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
8. Infrequent p53 mutations in arsenic-related skin lesions.
Castrén K; Ranki A; Welsh JA; Vähäkangas KH
Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
[TBL] [Abstract][Full Text] [Related]
9. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
[TBL] [Abstract][Full Text] [Related]
10. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.
Kashiwazaki H; Tonoki H; Tada M; Chiba I; Shindoh M; Totsuka Y; Iggo R; Moriuchi T
Oncogene; 1997 Nov; 15(22):2667-74. PubMed ID: 9400993
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
12. Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.
Yamazaki Y; Chiba I; Hirai A; Notani K; Kashiwazaki H; Tei K; Totsuka Y; Iizuka T; Kohgo T; Fukuda H
Am J Clin Oncol; 2003 Oct; 26(5):e124-9. PubMed ID: 14528086
[TBL] [Abstract][Full Text] [Related]
13. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
14. P16 UV mutations in human skin epithelial tumors.
Soufir N; Molès JP; Vilmer C; Moch C; Verola O; Rivet J; Tesniere A; Dubertret L; Basset-Seguin N
Oncogene; 1999 Sep; 18(39):5477-81. PubMed ID: 10498902
[TBL] [Abstract][Full Text] [Related]
15. TP53 mutations in human skin cancers.
Giglia-Mari G; Sarasin A
Hum Mutat; 2003 Mar; 21(3):217-28. PubMed ID: 12619107
[TBL] [Abstract][Full Text] [Related]
16. Chronic ultraviolet exposure-induced p53 gene alterations in Sencar mouse skin carcinogenesis model.
Tong Y; Smith MA; Tucker SB
J Toxicol Environ Health; 1997 Jun; 51(3):219-34. PubMed ID: 9183379
[TBL] [Abstract][Full Text] [Related]
17. Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma.
Bäckvall H; Asplund A; Gustafsson A; Sivertsson A; Lundeberg J; Ponten F
Mutat Res; 2005 Apr; 571(1-2):65-79. PubMed ID: 15748639
[TBL] [Abstract][Full Text] [Related]
18. Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele.
van der Riet P; Karp D; Farmer E; Wei Q; Grossman L; Tokino K; Ruppert JM; Sidransky D
Cancer Res; 1994 Jan; 54(1):25-7. PubMed ID: 8261448
[TBL] [Abstract][Full Text] [Related]
19. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
[TBL] [Abstract][Full Text] [Related]
20. p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer.
Bendesky A; Rosales A; Salazar AM; Sordo M; Peniche J; Ostrosky-Wegman P
Mutat Res; 2007 Jun; 619(1-2):38-44. PubMed ID: 17403527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
